SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-018578
Filing Date
2016-05-09
Accepted
2016-05-09 16:08:19
Documents
39
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fate-10q_20160331.htm 10-Q 998668
2 EX-31.1 fate-ex311_8.htm EX-31.1 9077
3 EX-32.1 fate-ex321_9.htm EX-32.1 5419
  Complete submission text file 0001564590-16-018578.txt   3733546

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT fate-20160331.xml EX-101.INS 678559
5 XBRL TAXONOMY EXTENSION SCHEMA fate-20160331.xsd EX-101.SCH 32668
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fate-20160331_cal.xml EX-101.CAL 36115
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fate-20160331_def.xml EX-101.DEF 121067
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE fate-20160331_lab.xml EX-101.LAB 290602
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fate-20160331_pre.xml EX-101.PRE 200580
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-36076 | Film No.: 161631705
SIC: 2836 Biological Products, (No Diagnostic Substances)